PERSONAL CAPITAL ADVISORS CORP – Eli Lilly and Company Transaction History
PERSONAL CAPITAL ADVISORS CORP portfolio value:
$16.01M
portfolio value
PERSONAL CAPITAL ADVISORS CORP quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.39% | 191 shares | 18K | $323.35 | 49.54K |
| Q2 2022 | share | Decrease | -2.90% | -1.47K shares | 1.44M | $324.23 | 49.35K |
| Q1 2022 | share | Increase | +2.76% | 1.36K shares | 915K | $286.37 | 50.82K |
| Q4 2021 | share | Increase | +5.79% | 2.70K shares | 2.83M | $277.25 | 49.46K |
| Q3 2021 | share | Increase | +2.70% | 1.23K shares | 354K | $230.3 | 46.75K |
| Q2 2021 | share | Increase | +14.04% | 5.60K shares | 2.99M | $228.04 | 45.52K |
| Q1 2021 | share | Increase | +15.47% | 5.34K shares | 1.62M | $184.81 | 39.92K |
| Q4 2020 | share | Increase | +18.74% | 5.45K shares | 1.52M | $166.32 | 34.57K |
| Q3 2020 | share | Increase | +10.52% | 2.77K shares | -15K | $145.05 | 29.11K |
| Q2 2020 | share | Decrease | -25.14% | -8.84K shares | -570K | $160.1 | 26.34K |
| Q1 2020 | share | Increase | +4.34% | 1.46K shares | 462K | $134.64 | 35.19K |
| Q4 2019 | share | Increase | +20.80% | 5.80K shares | 1.31M | $126.91 | 33.72K |
| Q3 2019 | share | Increase | +17.63% | 4.18K shares | 492K | $107.36 | 27.91K |
| Q2 2019 | share | Increase | +20.06% | 3.96K shares | 65K | $105.74 | 23.73K |
| Q1 2019 | share | Increase | +12.06% | 2.12K shares | 523K | $123.17 | 19.77K |
| Q4 2018 | share | Increase | +32.81% | 4.35K shares | 616K | $109.26 | 17.64K |
| Q3 2018 | share | Increase | +31.97% | 3.21K shares | 567K | $100.8 | 13.28K |
| Q2 2018 | share | Increase | +81.83% | 4.53K shares | 431K | $79.72 | 10.06K |
| Q1 2018 | share | Increase | +76.87% | 2.40K shares | 164K | $71.78 | 5.53K |
| Q4 2017 | share | Increase | 0.00% | 3.13K shares | 264K | $77.79 | 3.13K |